205 related articles for article (PubMed ID: 38424613)
1. Multi-omics approaches for drug-response characterization in primary biliary cholangitis and autoimmune hepatitis variant syndrome.
Yang F; Zhou L; Shen Y; Wang X; Fan X; Yang L
J Transl Med; 2024 Feb; 22(1):214. PubMed ID: 38424613
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
[TBL] [Abstract][Full Text] [Related]
3. Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis.
Ma ZH; Wang XM; Wu RH; Hao DL; Sun LC; Li P; Niu JQ
World J Gastroenterol; 2022 Oct; 28(39):5764-5783. PubMed ID: 36338890
[TBL] [Abstract][Full Text] [Related]
4. Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis.
Ozaslan E; Efe C; Akbulut S; Purnak T; Savas B; Erden E; Altiparmak E
Hepatogastroenterology; 2010; 57(99-100):441-6. PubMed ID: 20698205
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes.
Park Y; Cho Y; Cho EJ; Kim YJ
Clin Mol Hepatol; 2015 Jun; 21(2):150-7. PubMed ID: 26157752
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center.
Nejad SEM; Heiat M; Javanbakht M; Alavian SM; Haris MAA
BMC Gastroenterol; 2024 Jan; 24(1):17. PubMed ID: 38178070
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune hepatitis - primary biliary cholangitis overlap syndrome. Long-term outcomes of a retrospective cohort in a university hospital.
Martínez Casas OY; Díaz Ramírez GS; Marín Zuluaga JI; Santos Ó; Muñoz Maya O; Donado Gómez JH; Restrepo Gutiérrez JC
Gastroenterol Hepatol; 2018 Nov; 41(9):544-552. PubMed ID: 30017212
[TBL] [Abstract][Full Text] [Related]
8. A Case of Autoimmune Hepatitis/Primary Biliary Cholangitis Overlap Syndrome during Treatment with Brodalumab for Generalized Pustular Psoriasis.
Okazaki S; Hoashi T; Saeki H; Kanda N
J Nippon Med Sch; 2021; 88(6):569-573. PubMed ID: 34980743
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous development of an autoimmune hepatitis - primary biliary cholangitis overlap syndrome in dnTGFβRII Aire
Long J; Yang SY; Huang MX; Luo PY; Li L; Tsuneyama K; Ansari AA; Lu L; Gershwin ME; Lian ZX; Zhao ZB
J Pathol; 2023 Jun; 260(2):222-234. PubMed ID: 36853094
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease.
Duengelhoef P; Hartl J; Rüther D; Steinmann S; Brehm TT; Weltzsch JP; Glaser F; Schaub GM; Sterneck M; Sebode M; Weiler-Normann C; Addo MM; Lütgehetmann M; Haag F; Schramm C; Schulze Zur Wiesch J; Lohse AW
United European Gastroenterol J; 2022 Apr; 10(3):319-329. PubMed ID: 35289983
[TBL] [Abstract][Full Text] [Related]
12. [A case with HTLV-I associated myelopathy (HAM) accompanied by primary biliary cirrhosis (PBC) and autoimmune hepatitis (AIH)].
Nagami S; Konisi T; Kataoka H; Kikui S; Takayanagi T; Suzumura A
Rinsho Shinkeigaku; 1999 Nov; 39(11):1132-4. PubMed ID: 10689935
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome.
Braga MH; Cançado GGL; Bittencourt PL; Couto CA; Guedes LV; Lima AMC; Ferraz MLG; Villela-Nogueira CA; Nardelli MJ; Faria LC; Gomes NMF; Oliveira EMG; Rotman V; Oliveira MB; da Cunha SMCF; Cunha-Silva M; Mendes LSC; Ivantes CAP; Codes L; de Almeida E Borges VF; Pace FHL; Pessoa MG; Signorelli IV; Coral GP; Filho JG; Chagas AL; Terrabuio DRB; Cançado ELR;
Ann Hepatol; 2023; 28(4):101105. PubMed ID: 37088418
[TBL] [Abstract][Full Text] [Related]
14. miR-425 regulates inflammatory cytokine production in CD4
Nakagawa R; Muroyama R; Saeki C; Goto K; Kaise Y; Koike K; Nakano M; Matsubara Y; Takano K; Ito S; Saruta M; Kato N; Zeniya M
J Hepatol; 2017 Jun; 66(6):1223-1230. PubMed ID: 28192189
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis.
Wang Q; Selmi C; Zhou X; Qiu D; Li Z; Miao Q; Chen X; Wang J; Krawitt EL; Gershwin ME; Han Y; Ma X
J Autoimmun; 2013 Mar; 41():140-5. PubMed ID: 23187010
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive prediction of insufficient biochemical response after ursodeoxycholic acid treatment in patients with primary biliary cholangitis based on pretreatment nonenhanced MRI.
Zhang Y; Fan X; Song B; Liu Y; Chen Y; Zheng T; Guo Y; Duan T; Huang Z; Yang L
Eur Radiol; 2024 Feb; 34(2):1268-1279. PubMed ID: 37581659
[TBL] [Abstract][Full Text] [Related]
17. Immune signatures in variant syndromes of primary biliary cholangitis and autoimmune hepatitis.
Schultheiß C; Steinmann S; Willscher E; Paschold L; Lohse AW; Binder M
Hepatol Commun; 2023 May; 7(5):. PubMed ID: 37102762
[TBL] [Abstract][Full Text] [Related]
18. Transitions between variant forms of primary biliary cirrhosis during long-term follow-up.
Lindgren S; Glaumann H; Almer S; Bergquist A; Björnsson E; Broomé U; Danielsson A; Lebrun B; Prytz H; Olsson R
Eur J Intern Med; 2009 Jul; 20(4):398-402. PubMed ID: 19524182
[TBL] [Abstract][Full Text] [Related]
19. Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis.
Efe C; Ozaslan E; Heurgué-Berlot A; Kav T; Masi C; Purnak T; Torgutalp M; Muratori L; Bresson-Hadni S; Thiéfin G; Schiano TD; Muratori P; Wahlin S
Eur J Gastroenterol Hepatol; 2014 May; 26(5):532-7. PubMed ID: 24614697
[TBL] [Abstract][Full Text] [Related]
20. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome.
Muratori P; Granito A; Pappas G; Pendino GM; Quarneti C; Cicola R; Menichella R; Ferri S; Cassani F; Bianchi FB; Lenzi M; Muratori L
Am J Gastroenterol; 2009 Jun; 104(6):1420-5. PubMed ID: 19491855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
